An
impressive development has been achieved toward the production of
well-defined “smart” inorganic nanoparticles, in which
the physicochemical properties can be controlled and predicted to
a high degree of accuracy. Nanoparticle design is indeed highly advanced,
multimodal and multitargeting being the norm, yet we do not fully
understand the obstacles that nanoparticles face when used in vivo.
Increased cooperation between chemists and biochemists, immunologists
and physicists, has allowed us to think outside the box, and we are
slowly starting to understand the interactions that nanoparticles
undergo under more realistic situations. Importantly, such an understanding
involves awareness about the limitations when assessing the influence
of such inorganic nanoparticles on biological entities and vice versa,
as well as the development of new validation strategies.